Open AccessImportance of Pediatric Inclusion in COVID-19 Therapeutic Trials
Author(s) -
Vanessa Raabe,
Jennifer Lighter,
Arthur L. Caplan,
Adam J. Ratner
Publication year - 2020
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa656
Subject(s) - covid-19 , clinical trial , medicine , inclusion (mineral) , therapeutic approach , disease , psychology , virology , infectious disease (medical specialty) , outbreak , social psychology
Pediatric patients are excluded from most coronavirus disease 2019 (COVID-19) therapeutic trials. We outline a rationale for the inclusion of children in COVID-19 therapeutic trials, which enabled us to include children of all ages in a therapeutic COVID-19 trial at our institution.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom